Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for pain control after osmotic dilator insertion
NCT03080493Phase 4Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin in pain, sponsored by University of California, Davis. Started Mar 2017; status: completed.
02
Drugs
gabapentin
03
Conditions
pain
Beyond the preview
Go deeper on NCT03080493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080493.